1Zornoff LA,Paiva SA,Matsubara BB,et al.Combination therapy with angiotensin converting enzyme inhibition and AT1 receptor inhibitor on ventricular remodeling after myocardial infarction in rats[].Journal of Cardiovascular Pharmacology.2000
2Richer C,Gervais M,Fornes P,et al.Combined selective angiotensin II AT1-receptor blockade and angiotensin I-converting enzyme inhibition on coronary flow reserve in postischemic heart failure in rats[].Journal of Cardiovascular Pharmacology.1999
3Schieffer B,Wirger A,Meybrunn M,et al.Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat[].Circulation.1994
4Van Krimpen C,Smits JFM,Cleutjens JPM,et al.DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril[].Journal of Molecular and Cellular Cardiology.1991
5Lo M,Liu K-L,Lantelme P,et al.Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats[].The Journal of Clinical Investigation.1995
6Cavasin MA,Yang X-P,Liu Y-H,et al.Effects of ACE inhibitor, AT1 antagonist, and combined treatment in mice with heart failure[].Journal of Cardiovascular Pharmacology.2000
7Booz GW,Baker KM.Molecular signaling mechanisms controling growth and function of cardiac fibroblasts[].Cardiovascular Research.1995
8Taylor K,Patten RD,Smith JJ,et al.Divergent effects of angiotensinconverting enzyme inhibition and angiotensin II-receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats[].Journal of Cardiovascular Pharmacology.1998
9McDonald KM,Garr M,Carlyle PF,et al.Relative effects of α1adrenoceptor blockade, converting enzyme inhibitor therapy, and angiotensin II subtype 1 receptor blockade on ventricular remodeling in the dog[].Circulation.1994
3Viskin S,Kitzis I,Lev E,et al.Treatment with beta-adrenenergic blocking agents after MI:form radomized tridsizo chinical practice[J].J Am Coil Cardiol,1995,25(18):1327-1332.
4Barron HV,Viskin S,Lundstrom RJ,et al.Effect B-adrenergic bloc-king agents on mortality rate in patients not reras cubrized after myo-cardial infarction:date from aarge HMO[J].Am Heart J,1997,134(10):608-613.
